[go: up one dir, main page]

NO20012428L - Substituerte kaprolaktamer, farmasöytiske sammensetninger som inneholder dem og deres anvendelse ved behandling av tumorer - Google Patents

Substituerte kaprolaktamer, farmasöytiske sammensetninger som inneholder dem og deres anvendelse ved behandling av tumorer

Info

Publication number
NO20012428L
NO20012428L NO20012428A NO20012428A NO20012428L NO 20012428 L NO20012428 L NO 20012428L NO 20012428 A NO20012428 A NO 20012428A NO 20012428 A NO20012428 A NO 20012428A NO 20012428 L NO20012428 L NO 20012428L
Authority
NO
Norway
Prior art keywords
tumors
treatment
pharmaceutical compositions
compositions containing
compounds
Prior art date
Application number
NO20012428A
Other languages
English (en)
Norwegian (no)
Other versions
NO20012428D0 (no
Inventor
Frederick Ray Kinder Jr
Kenneth Walter Bair
Christopher Turchik Jagoe
Richard William Versace
Sompong Wattanasin
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20012428D0 publication Critical patent/NO20012428D0/no
Publication of NO20012428L publication Critical patent/NO20012428L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08—Oxygen atoms
    • C07D223/10—Oxygen atoms attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20012428A 1998-11-17 2001-05-16 Substituerte kaprolaktamer, farmasöytiske sammensetninger som inneholder dem og deres anvendelse ved behandling av tumorer NO20012428L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19335498A 1998-11-17 1998-11-17
PCT/EP1999/008767 WO2000029382A1 (en) 1998-11-17 1999-11-15 Certain substituted caprolactams, pharmaceutical compositions containing them and their use in treating tumors

Publications (2)

Publication Number Publication Date
NO20012428D0 NO20012428D0 (no) 2001-05-16
NO20012428L true NO20012428L (no) 2001-07-17

Family

ID=22713307

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012428A NO20012428L (no) 1998-11-17 2001-05-16 Substituerte kaprolaktamer, farmasöytiske sammensetninger som inneholder dem og deres anvendelse ved behandling av tumorer

Country Status (25)

Country Link
EP (1) EP1131297B1 (sk)
JP (1) JP3550545B2 (sk)
KR (1) KR20010080461A (sk)
CN (1) CN1187333C (sk)
AR (1) AR023914A1 (sk)
AT (1) ATE264309T1 (sk)
AU (1) AU748016B2 (sk)
BR (1) BR9915436A (sk)
CA (1) CA2347773C (sk)
CO (1) CO5140099A1 (sk)
CZ (1) CZ20011707A3 (sk)
DE (1) DE69916488T2 (sk)
ES (1) ES2221463T3 (sk)
HU (1) HUP0104224A3 (sk)
ID (1) ID28343A (sk)
IL (1) IL142701A0 (sk)
NO (1) NO20012428L (sk)
PE (1) PE20001241A1 (sk)
PL (1) PL347633A1 (sk)
PT (1) PT1131297E (sk)
SK (1) SK6692001A3 (sk)
TR (1) TR200101366T2 (sk)
UY (2) UY25807A1 (sk)
WO (1) WO2000029382A1 (sk)
ZA (1) ZA200103419B (sk)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003532711A (ja) * 2000-05-11 2003-11-05 ノバルティス アクチエンゲゼルシャフト 置換カプロラクタム炭酸エステルおよびカプロラクタムエーテル、およびそれらの抗腫瘍薬としての使用
WO2002072555A1 (en) * 2001-03-12 2002-09-19 Novartis Ag Process for preparing certain substituted caprolactams
JP2006528611A (ja) * 2003-07-25 2006-12-21 ノバルティス アクチエンゲゼルシャフト 置換ラクタムおよびそれらの抗がん剤としての使用
US7153846B2 (en) 2003-10-24 2006-12-26 Sanofi-Aventis Deutschland Gmbh Bengamide derivatives, process for preparing them, and their use
DE10349669B3 (de) * 2003-10-24 2005-05-25 Aventis Pharma Deutschland Gmbh Bengamide-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
FR2878528B1 (fr) * 2004-11-29 2008-05-16 Aventis Pharma Sa 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
FR2878525B1 (fr) * 2004-11-29 2007-02-23 Aventis Pharma Sa Bengamides possedant un cycle caprolactame substitue, procede de preparation, compositions les contenant et utilisation
FR2901555A1 (fr) 2006-05-24 2007-11-30 Sanofi Aventis Sa 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzothiazepine, leur preparation, compositions les contenant et utilisation
FR2901556A1 (fr) * 2006-05-24 2007-11-30 Sanofi Aventis Sa Derives de 2-alcoxy-3,4,5-trihydroxy-alkylamide, leur preparation, compositions les contenant et utilisation
FR2901554B1 (fr) 2006-05-24 2011-04-01 Sanofi Aventis 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzazepine, leur preparation, compositions les contenant et utilisation
WO2011157793A1 (en) 2010-06-17 2011-12-22 Novartis Ag Piperidinyl substituted 1,3-dihydro-benzoimidazol-2-ylideneamine derivatives
WO2011157787A1 (en) 2010-06-17 2011-12-22 Novartis Ag Biphenyl substituted 1,3-dihydro-benzoimidazol-2-ylideneamine derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9411841D0 (en) * 1994-06-14 1994-08-03 Pharma Mar Sa New antitumoral compounds from jaspis sponge

Also Published As

Publication number Publication date
HUP0104224A3 (en) 2002-04-29
JP3550545B2 (ja) 2004-08-04
ATE264309T1 (de) 2004-04-15
ID28343A (id) 2001-05-17
PT1131297E (pt) 2004-08-31
BR9915436A (pt) 2001-08-07
AR023914A1 (es) 2002-09-04
CA2347773C (en) 2009-03-10
SK6692001A3 (en) 2001-10-08
CN1326445A (zh) 2001-12-12
DE69916488T2 (de) 2005-03-24
ZA200103419B (en) 2002-06-26
PL347633A1 (en) 2002-04-22
AU748016B2 (en) 2002-05-30
JP2002529536A (ja) 2002-09-10
UY25807A1 (es) 2001-08-27
AU1506000A (en) 2000-06-05
TR200101366T2 (tr) 2001-10-22
UY26036A1 (es) 2001-06-29
NO20012428D0 (no) 2001-05-16
EP1131297A1 (en) 2001-09-12
KR20010080461A (ko) 2001-08-22
PE20001241A1 (es) 2000-11-24
CA2347773A1 (en) 2000-05-25
CZ20011707A3 (cs) 2001-08-15
WO2000029382A1 (en) 2000-05-25
CO5140099A1 (es) 2002-03-22
CN1187333C (zh) 2005-02-02
IL142701A0 (en) 2002-03-10
EP1131297B1 (en) 2004-04-14
HUP0104224A2 (hu) 2002-03-28
ES2221463T3 (es) 2004-12-16
DE69916488D1 (de) 2004-05-19

Similar Documents

Publication Publication Date Title
NO991732L (no) Nye heterocyklylmetylsubstituerte pyrazolderivater
NO20013003L (no) Kinolin-derivater
DE60112609D1 (en) Pyrazolopyridine
NO971862D0 (no) Nye inhibitorer av metalloprotease, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
EE05091B1 (et) Oligosahhariidid, nende valmistamismeetod ja kasutamine ning farmatseutilised kompositsioonid
DE60112330D1 (en) Pyrazolopyridinderivate
BR0209127A (pt) compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos
NO20006645D0 (no) Ny form av irbesartan, fremgangsmåte for å oppnå den nevnte form og farmasöytiske preparater inneholdende den samme
UA66865C2 (uk) Інденопіролокарбазоли, фармацевтична композиція, спосіб інгібування кіназної активності та спосіб лікування (варіанти)
NO20012428L (no) Substituerte kaprolaktamer, farmasöytiske sammensetninger som inneholder dem og deres anvendelse ved behandling av tumorer
MXPA03001463A (es) Derivados de benzofurano o benzotiofeno de aminoalquilbenzoil, metodo para preparar los mismos y composiciones que los contienen.
NO20030802D0 (no) Aminoalkoksybenzoyl-benzofuran- eller benzotiofenderivater, fremgangsmåte for deres fremstilling og preparater inneholdende de samme
CA2266759A1 (en) 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
DK1355906T3 (da) 2H-1-benzopyranderivater, fremgangsmåder til deres fremstilling og farmaceutiske sammensætninger indeholdende dem
AU6415994A (en) Substituted caprolactams and derivatives thereof useful for treatment of hiv disease
NO991589L (no) Nye 3-,5- og/eller 6-substituerte analoger av swainsonin, fremgangsmÕter for deres fremstilling og deres anvendelse som terapeutiske midler
NO20014803D0 (no) Pyrido-tieno-diazepiner, fremgangsmåte for fremstilling derav og farmasöytiske blandinger inneholdende dem
NO20053825L (no) Thienopyridazinoner og deres anvendelse ved modulering av autoimmune sykdommer.
NO20002114D0 (no) Bicykliske forbindelser, fremgangsmÕte for deres fremstilling og farmasøytiske sammensetninger inneholdende dem
NO20030801D0 (no) Aminoalkenylbenzoyl-benzofuran- eller benzotiofenderivater, fremgangsmåte for deres fremstilling og preparater inneholdende de samme
NO972111D0 (no) 6-Metoksy-1H-benzotriazol-5-karboksamid-derivater, fremgangsmåte ved deres fremstilling og medisinske sammensetninger inneholdende dem
NO20025393L (no) Optis 2-aminotetralinderivater, fremgangsmåte ved fremstilling derav og terapeutisk anvendelse av farmasöytisk anvendelse av farmasöytiskesammensetningerinneholdende dem
NO981687L (no) Lubeluzol N-oksid
WO2000037465A3 (en) Novel derivatives of swainsonine, processes for their preparation, and their use as therapeutic agents
ECSP993209A (es) Ciertas caprolactamas sustituidas, composiciones farmaceuticas que las contienen, y su uso en el tratamiento de tumores

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application